News Summary: Nutrition sale boosts Pfizer 4Q net

Published



STRONG RESULTS: Pfizer Inc. posted sharply higher fourth-quarter net income as tight spending controls and a huge gain from selling its nutrition business helped offset sharply lower sales of cholesterol fighter Lipitor.

THE NUMBERS: Pfizer reported net income of $6.3 billion, or 85 cents a share. Revenue fell 7 percent at $15 billion, hurt by generic rivals to Lipitor and other prescription drugs.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.